| GATA6 expression distinguishes classical and basal-like subtypes in advanced pancreatic cancer GM O’Kane, BT Grünwald, GH Jang, M Masoomian, S Picardo, RC Grant, ... Clinical Cancer Research 26 (18), 4901-4910, 2020 | 232 | 2020 |
| Spatially confined sub-tumor microenvironments in pancreatic cancer BT Grünwald, A Devisme, G Andrieux, F Vyas, K Aliar, CW McCloskey, ... Cell 184 (22), 5577-5592. e18, 2021 | 228 | 2021 |
| A four-chemokine signature is associated with a T-cell–inflamed phenotype in primary and metastatic pancreatic cancer JM Romero, B Grünwald, GH Jang, PP Bavi, A Jhaveri, M Masoomian, ... Clinical Cancer Research 26 (8), 1997-2010, 2020 | 112 | 2020 |
| Correction: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer GM O'Kane, BT Grünwald, GH Jang, M Masoomian, S Picardo, RC Grant, ... Clinical Cancer Research 28 (12), 2715-2715, 2022 | 2 | 2022 |
| Spatially confined sub-tumor microenvironments orchestrate pancreatic cancer pathobiology BT Grünwald, A Devisme, G Andrieux, F Vyas, K Aliar, CW McCloskey, ... bioRxiv, 2021.02. 18.431890, 2021 | 2 | 2021 |
| Hourglass, a rapid analysis framework for heterogeneous bioimaging data, identifies sex disparity in IL‐6/STAT3‐associated immune phenotypes in pancreatic cancer K Aliar, HR Waterhouse, F Vyas, N Krebs, B Zhang, E Poulton, N Chan, ... The Journal of Pathology 261 (4), 413-426, 2023 | 1 | 2023 |
| Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response via AP1 dichotomy in pancreatic cancer L Klein, M Tu, N Krebs, L Urbach, DG Grimm, MU Latif, F Penz, N Chan, ... bioRxiv, 2023.10. 30.563552, 2023 | 1 | 2023 |
| 1309P CD8+ T cell infiltration is associated with improved survival in advanced pancreatic cancer GM O'Kane, YQ Wang, R Gonzalez, G Jang, A Zhang, A Dodd, S Ramotar, ... Annals of Oncology 33, S1142, 2022 | 1 | 2022 |
| Abstract C059: Hub gene analysis identifies CAD as a potential mediator for drug resistance in pancreatic cancer F Vyas, B Grünwald, K Aliar, GH Jang, G O'Kane, T Kislinger, S Gallinger, ... Cancer Research 84 (2_Supplement), C059-C059, 2024 | | 2024 |
| Insulin receptor loss impairs mammary tumorigenesis in mice L Podmore, Y Poloz, C Iorio, S Mouaaz, K Nixon, P Smirnov, B McDonnell, ... Cell Reports 42 (11), 2023 | | 2023 |
| FABP7 Progenitors are a Targetable Metabolic Root in the BRCA1 Breast CW McCloskey, B Zhang, M Waas, G Abazari, F Vyas, K Aliar, ... bioRxiv, 2023.11. 02.565360, 2023 | | 2023 |
| Proteogenomic analysis of the PDAC epithelium reveals tissue markers of subtype identity and biology. BT Grunwald, F Vyas, M Geuenich, N Chan, R Gonzalez, K Aliar, N Krebs, ... CANCER RESEARCH 82 (22), 19-20, 2022 | | 2022 |
| Abstract A031: Proteogenomic analysis of the PDAC epithelium reveals tissue markers of subtype identity and biology BT Grünwald, F Vyas, M Geuenich, N Chan, R Gonzalez, K Aliar, N Krebs, ... Cancer Research 82 (22_Supplement), A031-A031, 2022 | | 2022 |
| Hourglass, a tool to mine bioimaging data, uncovers sex-disparities in the IL-6-associated T cell response in pancreatic tumors K Aliar, HR Waterhouse, F Vyas, N Krebs, E Poulton, B Zhang, N Chan, ... bioRxiv, 2022.09. 12.507618, 2022 | | 2022 |
| GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer (vol 26, pg 4901, 2020) GM O'Kane, BT Grunwald, GH Jang, M Masoomian, S Picardo, RC Grant, ... CLINICAL CANCER RESEARCH 28 (12), 2715-2715, 2022 | | 2022 |
| Abstract PO-107: Fibroblast differentiation trajectories elicit regional tissue states in pancreatic cancer BT Grünwald, C McCloskey, A Devisme, F Vyas, G Andrieux, K Aliar, ... Cancer Research 81 (22_Supplement), PO-107-PO-107, 2021 | | 2021 |
| Fibroblast differentiation trajectories elicit regional tissue states in pancreatic cancer. BT Grunwald, C McCloskey, A Devisme, F Vyas, G Andrieux, K Aliar, ... CANCER RESEARCH 81 (22), 73-73, 2021 | | 2021 |
| Abstract PR-002: Stromal phenotypic heterogeneity fosters pancreatic cancer progression BT Grünwald, A Devisme, F Vyas, G Andrieux, GH Jang, K Aliar, ... Cancer Research 80 (22_Supplement), PR-002-PR-002, 2020 | | 2020 |
